This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, D.-M.
Right arrow Articles by Hong, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, D.-M.
Right arrow Articles by Hong, S. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2005, p. 3489-3491, Vol. 49, No. 8
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.8.3489-3491.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

In Vitro Efficacy of the Combination of Ciprofloxacin and Cefotaxime against Vibrio vulnificus

Dong-Min Kim,1 Yong Lym,2 Sook Jin Jang,3* Hulin Han,3 Young Gi Kim,4 Choon-Hae Chung,1 and Soon Pyo Hong1

Division of Infectious Disease, Department of Internal Medicine,1 Department of Microbiology,2 Department of Laboratory Medicine, Chosun University College of Medicine, Clinical Research Institute, Gwang-Ju,3 R & D Center of Pharmaceuticals, CJ Corp., Kyonggi-Do, South Korea4

Received 1 February 2005/ Returned for modification 15 February 2005/ Accepted 25 April 2005

We performed time-kill studies of antimicrobial combinations that included minocycline, cefotaxime, and ciprofloxacin with Vibrio vulnificus ATCC 27562. Cefotaxime-plus-ciprofloxacin combinations acted synergistically against V. vulnificus in vitro, and this combination regimen can be a good choice as the empirical treatment for suspected necrotizing fasciitis due to V. vulnificus.


* Corresponding author. Mailing address: Department of Laboratory Medicine, Chosun University Medical School, 588 Seoseok-dong, Dong-gu, Gwang-Ju 501-717, South Korea. Phone: 82-62-220-3259. Fax: 82-62-232-2063. E-mail: sjbjang{at}chosun.ac.kr.


Antimicrobial Agents and Chemotherapy, August 2005, p. 3489-3491, Vol. 49, No. 8
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.8.3489-3491.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Roig, F. J., Llorens, A., Fouz, B., Amaro, C. (2009). Spontaneous Quinolone Resistance in the Zoonotic Serovar of Vibrio vulnificus. Appl. Environ. Microbiol. 75: 2577-2580 [Abstract] [Full Text]  
  • Liu, J.-W., Lee, I.-K., Tang, H.-J., Ko, W.-C., Lee, H.-C., Liu, Y.-C., Hsueh, P.-R., Chuang, Y.-C. (2006). Prognostic Factors and Antibiotics in Vibrio vulnificus Septicemia.. Arch Intern Med 166: 2117-2123 [Abstract] [Full Text]